When patients are diagnosed with cancer, treatment decisions often have to be made quickly. But many of the newest diagnostic tests that could help guide those decisions are still years away from…
Read More ➝
Prostate cancer is one of the most common cancers in men, but most cases do not need immediate treatment. Some grow so slowly they may never cause symptoms or affect long-term health….
Read More ➝
A new clinical trial published in the New England Journal of Medicine may change how some breast cancer patients are treated with radiation after chemotherapy and surgery. We spoke with Dr. Terry…
Read More ➝
How can inherited genetic differences help predict who’s more likely to benefit from cancer treatment—or experience severe side effects? That question is at the heart of two new studies we recently shared…
Read More ➝
Cancer treatment often involves multiple options based on general data about how most patients will respond to therapy. However, this approach may not be effective for everyone, as treatment responses and side…
Read More ➝
November is Prostate Cancer Awareness Month, so this month we’ve interviewed MiraKind’s founder, Dr. Joanne Weidhaas, about personalizing prostate cancer treatment and how patients can personalize their treatment choices with a new…
Read More ➝
In November 2020, we announced that we had undertaken new research into other genetic variants that are connected to cancer. Specifically, ones that affect prostate cancer.1 Our research has produced a lot…
Read More ➝